Chimeric antigen receptor T-cell therapy for multiple myeloma
Crossref DOI link: https://doi.org/10.1007/s12185-020-02827-8
Published Online: 2020-01-25
Published Print: 2020-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hosen, Naoki
Text and Data Mining valid from 2020-01-25
Version of Record valid from 2020-01-25
Article History
Received: 20 August 2019
Accepted: 15 January 2020
First Online: 25 January 2020
Compliance with ethical standards
:
: The author received a research funding from Otsuka Pharmaceutical Company.